Vanguard US Value Factor ETF

VFVA

市值 US$9.35億

Vanguard US Value Factor ETF is initiated with a 'Buy' rating, driven by robust price momentum and favorable market trends for value stocks. VFVA outperformed the Russell 3000 YTD with a 21% surge, supported by diversified exposure to 666 undervalued large, mid, and small-cap stocks. The fund trades at attractive valuations—13.9x earnings and 1.5x book—offers a 1.75% dividend yield, and maintains a low 0.13% expense ratio.

New market analysis from Vanguard suggests that U.S. value stocks might be a better buy than U.S. growth stocks for the next decade. The Vanguard Value Factor ETF has delivered 12.4% annualized returns for the past five years and has performed even better in the past year.

The Vanguard U.S. Value Factor ETF has gained about 28.5% over the past year and has delivered an annualized return of 10.96% since its inception eight years ago. The fund is actively managed and charges a slightly higher expense ratio than typical passive Vanguard ETFs.

Research from Vanguard indicates U.S. value stocks and small caps could outperform over the next 10 years. One fund to consider is the Vanguard Small-Cap Value ETF, with its 22 years of 9.5% annualized returns.

Vanguard research projects that value stocks and bonds could be good buys for the next few years. The Vanguard U.S. Value Factor ETF has outperformed the S&P 500 index over the past year and looks cheap by its P/E ratio.

Vanguard U.S. Value Factor ETF (BATS:VFVA) is built around an aggressive premise: find the cheapest U.S.

Vanguard US Value Factor ETF earns a Hold rating due to a decent value thesis but better alternatives elsewhere. VFVA's multi-factor approach blends value, momentum, and quality, but its broad mandate dilutes pure value exposure compared to IWN. The fund's low 0.13% expense ratio and sector tilts toward financials, industrials, and energy offer some macro resilience for 2026.

Vanguard U.S. Value Factor ETF remains a Hold due to macro conditions favoring growth over value stocks. VFVA's diversified portfolio lacks large-cap tech exposure, limiting upside as tech leads in current market regimes. Sector weights in Health Care and Financials, and cyclical exposure, present relative disadvantages amid slowing economic growth.

For most investors, the Vanguard Value ETF (NYSE:VTV) has been a reliable workhorse, providing broad exposure to large, established US companies trading at what are arguably reasonable valuations.

CVAR: Why You Should Avoid This High Fee Active All-Cap Value ETF